From: Annexin A5 as a marker for hepatocellular carcinoma in cirrhotic hepatitis C virus patients
Variables | Cirrhosis with HCC group (n = 44) | Cirrhosis without HCC group (n = 47) | P1value | Control group (n = 20) | P value |
---|---|---|---|---|---|
Age (years) | 57.7 ± 5.75 | 56.8 ± 6.89 | 0.968 (NS) | 54.5(50.5–60.5) | 0.337 (NS) |
Sex (M/F) | 23/21 | 27/20 | 0.751 (NS) | 10/10 | 0.587 (NS) |
MELD | 16.1 ± 4.16 | 15.1 ± 4.57 | 0.568 (NS) | – | – |
Child–Pugh class (A/B/C) | 12/20/12 | 14/18/14 | 0.733 (NS) | – | – |
ALT (U/L) | 51 ± 17.65 | 53.3 ± 15.94 | 0.761 (NS) | 11.9 ± 3.47 | < 0.001* (HS) |
AST(U/L) | 69 ± 23.39 | 68.2 ± 19.51 | 0.944 (NS) | 15.4 ± 4.83 | < 0.001* (HS) |
ALKP (U/L) | 107.60 ± 37.05 | 114.40 ± 41.84 | 0.068 (NS) | 48.6 ± 10.49 | < 0.001* (HS) |
GGT (mg/dl) | 51.09 ± 37.75 | 48.94 ± 26.37 | 0.818 (NS) | 14.6 ± 4.57 | < 0.001* (HS) |
INR | 1.5 ± 0.47 | 1.59 ± 0.51 | 0.542 (NS) | 1.005 ± 0.49 | < 0.001* (HS) |
PT(s) | 17.51 ± 4.21 | 18.62 ± 4.64 | 0.533 (NS) | 13.07 ± 0.18 | < 0.001* (HS) |
Total bilirubin (mg/dl) | 2.55 ± 1.61 | 2.59 ± 2.01 | 0.579 (NS) | 0.49 ± 0.25 | < 0.001* (HS) |
Albumin (g/dl) | 2.97 ± 0.72 | 2.54 ± 0.79 | 0.098 (NS) | 4.43 ± 0.59 | < 0.001* (HS) |
Platelet count (× 103/cm2) | 113.04 ± 24.94 | 111.32 ± 17.63 | 0.935 (NS) | 297.7 ± 17.87 | < 0.001* (HS) |
APRI score | 1.88 ± 0.58 | 1.93 ± 0.61 | 0.794 (NS) | 0.11 ± 0.03 | < 0.001* (HS) |
FIB-4 score | 5.47 ± 1.04 | 5.32 ± 1.37 | 0.709 (NS) | 0.57 ± 0.14 | < 0.001* (HS) |
Annexin A5 (ng/ml) | 3.89 ± 0.85 | 3.06 ± 0.88 | 0.041 (S) | 0.54 ± 0.11 | < 0.001* (HS) |
AFP (ng/ml) | 270 ± 35 | 98 ± 20 | < 0.001* (HS) | 5.3 ± 2.9 | < 0.001* (HS) |